This research study aims to test whether topiramate (a drug that is being used for seizure) will help individuals who have problems with both alcohol and nicotine. The investigators believe that individuals taking topiramate will be more successful at abstaining from both alcohol and nicotine than individuals taking placebo.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Continuous Smoking Abstinence in the Last 4 Weeks of Treatment Continuous Smoking Abstinence in the Last 4 Weeks of Treatment
Timeframe: Week 15 - 18 of the 18-week medication treatment
Percentage of Heavy Drinking Days (PHDD) in the Last 4 Weeks of Treatment
Timeframe: Week 15 - 18 of the 18-week medication treatment